Xylazine: A new medicine known as Xylazine, or “tranq,” has caused havoc in cities across the United States by causing deadly symptoms such as skin rotting.
The nation’s Food and Drug Administration (FDA) approved this “zombie drug” for use in veterinary medicine. It was also used to cut heroin, but according to the New York Post, it was recently discovered in fentanyl and other illegal substances.
An overdose of the non-opioid xylazine prevents a person from reacting to naloxone, also known as Narcan, the most commonly used overdose reversal medication, rendering it unsafe for humans.
Brooo, what’s happening in the USA🙆🏽♂️💀? pic.twitter.com/hUJCjZ5Xlx
— Oyindamola🙄 (@dammiedammie35) December 6, 2022
According to the news outlet, xylazine has been discovered in cities across the country in a report. The drug’s use is increasing at an exponential rate wherever it lands, resulting in outbreaks of skin infections and overdoses. The nationwide spread of xylazine poses a public health risk. It also foreshadows the future of the overdose crisis, which will be driven increasingly by powerful synthetic compounds mixed into potent combinations.
Also Read: Saudi’s next giga-project The Mukaab ,the size of 20 Empire State Buildings
According to The New York Post, Xylazine causes sedative-like symptoms such as excessive sleepiness and respiratory depression, as well as open sores that can become serious and spread quickly after repeated exposure. Because “tranq” is not classified as a controlled substance for humans or animals, hospitals rarely test for it using standard toxicology testing, leaving it in a perplexing and horrifying grey area.
Also Read: Malaysian Restaurant Serves Papad As ‘Asian Nachos’, Netizens Says ‘Culinary Crime’
In Philadelphia in 2021, approximately 90% of lab-tested dope samples contained xylazine, raising the risk of overdose when combined with other illegal narcotics. The high from opioids like fentanyl may last longer if xylazine acts as a “tranq,” which is why it is so appealing.
According to the New York City Department of Health, 2,668 people died in New York in 2021 as a result of xylazine overdoses, and experts are concerned that the medication will exacerbate the country’s current drug pandemic.